Elkfork Partners’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$650K Hold
18,734
0.02% 507
2019
Q2
$594K Buy
18,734
+3,196
+21% +$95K 0.01% 528
2019
Q1
$465K Buy
15,538
+2,992
+24% +$85.8K 0.01% 580
2018
Q4
$387K Hold
12,546
0.01% 592
2018
Q3
$476K Sell
12,546
-54,978
-81% -$2.08M 0.01% 610
2018
Q2
$2.59M Buy
67,524
+16,354
+32% +$551K 0.07% 231
2018
Q1
$1.73M Buy
51,170
+37,468
+273% +$1.44M 0.05% 250
2017
Q4
$608K Sell
13,702
-1,224
-8% -$55.8K 0.02% 481
2017
Q3
$748K Buy
14,926
+1,768
+13% +$90.3K 0.02% 387
2017
Q2
$695K Buy
13,158
+612
+5% +$32.8K 0.02% 404
2017
Q1
$697K Buy
12,546
+510
+4% +$28.1K 0.02% 379
2016
Q4
$627K Buy
+12,036
New +$581K 0.02% 375

Other funds holding PBH

Elkfork Partners's PBH Position: Q3 2019 in Review

Elkfork Partners held its Prestige Consumer Healthcare (PBH) position steady in Q3 2019 at 18,734 shares worth $650K. The position accounts for 0.02% of the portfolio, ranked #507.

Elkfork Partners first reported a position in PBH in Q4 2016 and has held it in 12 quarters since. The position peaked at $2.59M in Q2 2018. 230 funds tracked by Wall St. Rank hold PBH as of Q3 2019.

  • Elkfork Partners held 18,734 shares of Prestige Consumer Healthcare worth $650K as of Q3 2019.
  • Elkfork Partners left its Prestige Consumer Healthcare share count unchanged in Q3 2019.
  • Prestige Consumer Healthcare made up 0.02% of Elkfork Partners's portfolio in Q3 2019, its #507 holding.
  • Elkfork Partners first reported a position in Prestige Consumer Healthcare in Q4 2016 and has held it in 12 quarters since.
  • Elkfork Partners's Prestige Consumer Healthcare position peaked at $2.59M in Q2 2018.
  • 230 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.